LISA D'AGOSTINO: Open Payments
NPI 1649756545 · BOYNTON BEACH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,907 in 88 payments from 18 companies in 2025. Trend: 2023 $2,520 · 2024 $1,761 · 2025 $1,907
Food & beverage: $1,907
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 12 | $386 |
| ABBVIE INC. | 15 | $299 |
| Ardelyx, Inc. | 9 | $246 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $201 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 11 | $188 |
| Janssen Biotech, Inc. | 14 | $155 |
| Gilead Sciences, Inc. | 4 | $105 |
| Lilly USA, LLC | 2 | $52 |
| Aimmune Therapeutics, Inc. | 2 | $50 |
| VIVUS LLC | 2 | $39 |
Products named: REZDIFFRA, IBSRELA, ENTYVIO, TREMFYA, XIFAXAN, LINZESS, CREON, RINVOQ.
Industry payments across FL — which companies pay providers there.
